Cansortium Dividend

Dividend criteria checks 0/6

Cansortium does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield	2.3%
Next dividend pay date	n/a
Ex dividend date	n/a
Dividend per share	n/a
Earnings per share	-US$0.076
Dividend yield forecast in 3Y	n/a

Recent dividend updates

No updates

Recent updates

Cansortium Inc. (CSE:TIUM.U) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough

Jul 28

An Intrinsic Calculation For Cansortium Inc. (CSE:TIUM.U) Suggests It's 26% Undervalued

Mar 08

Does Cansortium (CSE:TIUM.U) Have A Healthy Balance Sheet?

Jan 09

Here's Why Cansortium (CSE:TIUM.U) Has A Meaningful Debt Burden

Sep 09

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if TIUM.U's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if TIUM.U's dividend payments have been increasing.

Dividend Yield vs Market

Cansortium Dividend Yield vs Market

How does TIUM.U dividend yield compare to the market?
Segment	Dividend Yield
Company (TIUM.U)	n/a
Market Bottom 25% (CA)	1.9%
Market Top 25% (CA)	6.5%
Industry Average (Pharmaceuticals)	2.3%
Analyst forecast in 3 Years (TIUM.U)	n/a

Notable Dividend: Unable to evaluate TIUM.U's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate TIUM.U's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate TIUM.U's payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as TIUM.U has not reported any payouts.

Cansortium Dividend

Dividend criteria checks 0/6

Key information

Recent dividend updates

Recent updates

Full year 2023 earnings released: US$0.078 loss per share (vs US$0.15 loss in FY 2022)

Cansortium Inc. to Report Q4, 2023 Results on Apr 29, 2024

Cansortium Inc.'s (CSE:TIUM.U) Shares Not Telling The Full Story

Third quarter 2023 earnings released: US$0.009 loss per share (vs US$0.022 loss in 3Q 2022)

Is Cansortium (CSE:TIUM.U) Using Too Much Debt?

Cansortium Inc. to Report Q3, 2023 Results on Nov 29, 2023

Cansortium Inc. to Report Q3, 2023 Results on Nov 13, 2023

Is Cansortium (CSE:TIUM.U) Using Debt Sensibly?

Second quarter 2023 earnings released: US$0.018 loss per share (vs US$0.014 loss in 2Q 2022)

Cansortium Inc. to Report Q2, 2023 Results on Aug 28, 2023

New major risk - Share price stability

Cansortium Inc. (CSE:TIUM.U) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough

Less than half of directors are independent

Cansortium Inc. Announces Board Changes

First quarter 2023 earnings released: US$0.027 loss per share (vs US$0.04 loss in 1Q 2022)

Cansortium Inc., Annual General Meeting, Jul 26, 2023

Cansortium Inc. Announces the Launch of Its New Cannabis-Infused Dark Chocolate Bar in Florida

Cansortium Inc. to Report Q1, 2023 Results on May 31, 2023

Full year 2022 earnings: EPS misses analyst expectations

An Intrinsic Calculation For Cansortium Inc. (CSE:TIUM.U) Suggests It's 26% Undervalued

Now 28% undervalued after recent price drop

Now 23% undervalued after recent price drop

Now 21% undervalued after recent price drop

Does Cansortium (CSE:TIUM.U) Have A Healthy Balance Sheet?

Price target decreased to US$0.83

No longer forecast to breakeven

Cansortium Inc. Revises Earnings Guidance for the Year 2022

Cansortium Inc. to Report Q3, 2022 Results on Nov 29, 2022

Cansortium Inc. Appoints Liora Boudin as Interim CFO

Cansortium Inc. Announces Resignation of Patricia Fonseca as Chief Financial Officer, Effective November 21, 2022

Cansortium Inc. Provides Business Update Following Hurricane Ian

Here's Why Cansortium (CSE:TIUM.U) Has A Meaningful Debt Burden

Second quarter 2022 earnings released: US$0.014 loss per share (vs US$0.11 loss in 2Q 2021)

Cansortium Inc. Provides Earnings Guidance for the Year 2022

Cansortium Inc. to Report Q2, 2022 Results on Aug 29, 2022

First quarter 2022 earnings released: US$0.04 loss per share (vs US$0.026 loss in 1Q 2021)

Cansortium Inc. Reaffirms Earnings Guidance for the Year 2022

Cansortium Inc. Provides Revenue Guidance for the Year 2022

No longer forecast to breakeven

High number of new and inexperienced directors

Cansortium Inc. announced that it has received $2.5 million in funding

Price target decreased to US$1.48

No longer forecast to breakeven

Third quarter 2021 earnings: Revenues miss analyst expectations

Cansortium Inc. Receives Approval from Florida Department of Health to Commence Operation

Second quarter 2021 earnings released

Cansortium Inc. Revises Revenue Guidance for the Year 2021

Independent Director David Abrams has left the company

Independent Chairman Neal Hochberg has left the company

First quarter 2021 earnings released

Cansortium Inc. Reiterates Financial Guidance for 2021

Cansortium Inc. Provides Consolidated Financial Outlook for 2021

Cansortium Inc. announced that it has received $17.2 million in funding

Cansortium Inc. announced that it expects to receive $12 million in funding

New 90-day high: US$0.82

Analysts update estimates

Cansortium Inc. Announces Executive Changes

New 90-day high: US$0.81

Cansortium Inc. announced that it has received $0.674218 million in funding

Cansortium Inc. Announces Board Changes

New 90-day high: US$0.77

New 90-day high: US$0.52

Cansortium Inc. Announces Executive Changes

New 90-day high: US$0.46

Revenue beats expectations, earnings disappoint

New 90-day high: US$0.39

Cansortium Inc. Commences Edibles Sales in Florida Following Receipt of Regulatory Approval

New 90-day low: US$0.29

Cansortium Inc. Appoints Robert Beasley as Chief Executive Officer

Price target lowered to US$0.83

Cansortium Inc. announced that it has received $2.082102 million in funding

Stability and Growth of Payments

Dividend Yield vs Market

Earnings Payout to Shareholders

Cash Payout to Shareholders